Lazard Asset Management LLC Cure Vac N.V. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.31 - $4.99 $5,689 - $12,290	-2,463 Reduced 95.91%	105 $0
Q1 2024 May 14, 2024	SELL	$2.94 - $4.34 $4,180 - $6,171	-1,422 Reduced 35.64%	2,568 $7,000
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $629 - $1,019	159 Added 4.15%	3,990 $16,000
Q3 2023 Nov 14, 2023	BUY	$6.5 - $10.77 $1,150 - $1,906	177 Added 4.84%	3,831 $26,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $990 - $1,813	148 Added 4.22%	3,654 $38,000
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $22,368 - $43,825	3,506 New	3,506 $24,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $469M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.